126
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

HPTLC METHOD FOR ANALYSIS OF SERTRALINE IN PURE BULK DRUG AND LIPIDIC NANO DELIVERY SYSTEM: A STRESS DEGRADATION STUDIES

, , , , , & show all
Pages 700-716 | Published online: 26 Feb 2013
 

Abstract

A sensitive, selective, precise, and stability-indicating, high-performance, thin-layer chromatographic (HPTLC) method for analysis of sertraline, both as a bulk drug and in house formulation, was developed and validated. The method employed thin-layer chromatographic (TLC) aluminium plates precoated with silica gel 60F-254 as the stationary phase. The solvent system consisted of Toulene/Ethyl acetate/Ammonia (1:5:0.1, v/v) as a mobile phase. The densitometric analysis were carried out at 273 nm using Camag TLC scanner which generated compact spots for SRT (R f  = 0.70 ± 0.02). The linear regression data for the calibration plots showed good linear relationship with r2 = 0.998 in the concentration range of 25–2000 ng spot−1. Sertraline was subjected to acid and alkali hydrolysis, oxidation, photodegradation, and dry heat treatment. Also, the degraded products were well separated from the pure drug. The method was validated for precision, accuracy, ruggedness, and recovery. As the method could effectively separate the drug from its degradation products, it can be employed as a stability indicating one. Moreover, the proposed HPTLC method was utilized to investigate the kinetics of acid and base degradation process.

ACKNOWLEDGMENT

Md. A. Rahman is highly grateful to the Indian Council of Medical Research (ICMR), Government of India for approval of the project to provide financial assistance in the form of senior research fellowship (SRF). The authors are also thankful to R&D division, Ranbaxy, Gurgaon (India) for providing the gift sample of the drug.

Notes

a  = Degradation rate constant.

b  = half-life.

c  = shelf-life (time left for 90% potency).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.